Susquehanna International Group’s ProShares UltraShort NASDAQ Biotechnology BIS Stock Holding History

Susquehanna International Group’s Portfolio BIS Stock Details BIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,538	Closed	-$467K	–	8824
2018 Q4	$467K	Buy	+2,538	New	+$409K	﹤0.01%	6158
2018 Q1	–	Sell	-2,063	Closed	-$364K	–	9312
2017 Q4	$364K	Buy	+2,063	New	+$366K	﹤0.01%	7233
2016 Q1	–	Sell	-8,200	Closed	-$1.88M	–	8996
2015 Q4	$1.88M	Sell	8,200 -3,013	-27%	-$775K	﹤0.01%	4150
2015 Q3	$3.46M	Sell	11,213 -26,000	-70%	-$6.13M	﹤0.01%	3255
2015 Q2	$8.96M	Buy	37,213 +34,663	+1,359%	+$8.6M	﹤0.01%	2137
2015 Q1	$704K	Buy	2,550 +1,387	+119%	+$424K	﹤0.01%	6460
2014 Q4	$428K	Buy	1,163 +150	+15%	+$62.5K	﹤0.01%	7519
2014 Q3	$488K	Sell	1,013 -1,002	-50%	-$533K	﹤0.01%	7262
2014 Q2	$1.15M	Sell	2,015 -1,563	-44%	-$1.08M	﹤0.01%	5757
2014 Q1	$2.55M	Buy	+3,578	New	+$2.39M	﹤0.01%	3917

Other funds holding BIS

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's BIS Position: Q1 2026 in Review

Susquehanna International Group increased its ProShares UltraShort NASDAQ Biotechnology (BIS) stake by 129% in Q1 2026, buying an estimated $333K and bringing the position to 32,974 shares worth $582K. The position accounts for ﹤0.01% of the portfolio, ranked #9272.

Susquehanna International Group first reported a position in BIS in Q2 2013 and has held it in 35 quarters since. The position peaked at $3.63M in Q3 2015. 4 funds tracked by Wall St. Rank hold BIS as of Q1 2026.

Susquehanna International Group held 32,974 shares of ProShares UltraShort NASDAQ Biotechnology worth $582K as of Q1 2026.
Susquehanna International Group bought 18,598 ProShares UltraShort NASDAQ Biotechnology shares in Q1 2026, an estimated $333K.
ProShares UltraShort NASDAQ Biotechnology made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #9272 holding.
Susquehanna International Group first reported a position in ProShares UltraShort NASDAQ Biotechnology in Q2 2013 and has held it in 35 quarters since.
Susquehanna International Group's ProShares UltraShort NASDAQ Biotechnology position peaked at $3.63M in Q3 2015.
4 funds tracked by Wall St. Rank held ProShares UltraShort NASDAQ Biotechnology as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.